Cordova Ashley 4
4 · NovoCure Ltd · Filed Mar 6, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Cordova Ashley
Former Chief Executive Officer
Transactions
- Award
Ordinary Shares
2025-03-04$18.19/sh+151,181$2,749,982→ 355,186 total - Award
Stock Options (Right to buy)
2025-03-04$18.19/sh+224,123$4,076,797→ 224,123 totalExercise: $18.19From: 2026-03-04Exp: 2035-03-03→ Ordinary Shares (224,123 underlying)
Footnotes (2)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
- [F2]Options to buy 224,123 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.